Większa skuteczność nilotynibu niż imatynibu w leczeniu przewlekłej białaczki szpikowej w fazie przewlekłej. Analiza aktualnych wyników badania ENESTnd i ENESTcmr

Inhibitory kinaz tyrozynowych II generacji jako pierwszy wybór w przewlekłej białaczce szpikowej (CML) w fazie przewlekłej zwiększają skuteczność terapii i poprawiają rokowanie. Pierwotnym celem badania ENESTnd było poró...

Application of molecular markers in the diagnostics of thyroid focal lesions – current state of knowledge

Thyroid nodular disease is a common disorder and affects about 20% of adult polish population. Due to the fact that methods currently applied in routine assessment of these changes often do not provide accurate diagnosis...

Childhood Cancer Survivorship Late Cardiotoxicity, and CV Prevention

Everolimus – effectively reverses acquired resistance on endocrine therapy of patients with advanced breast cancer. A case report

Breast cancer is the most common malignancy among women in Poland. Endocrine therapy is the first line of treatment in hormone-receptor-positive advanced breast cancer. Progression during endocrine therapy is unavoidable...

Compliance, adherence, persistence – causes and consequences of non-adherence to medical recommendations

Patients’ non-adherence is among the most serious health problems of mankind. It was recognized as one of the major barriers to achieving benefits from therapies based on current medical knowledge. The aim of this paper...